Get MotifBio Email Alerts
Subscribe
About Us
Motif Bio is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA.
Recent News
- Motif Bio to participate at upcoming Jefferies London Healthcare Conference October 31, 2018
- Motif Bio Presents New Iclaprim Data at IDWeek October 3, 2018
- Motif Bio Reports Half-Year 2018 Financial Results and Operational Progress September 25, 2018
Navigation
Contact Us
Motif Bio plc
201 Temple Chambers
3-7 Temple Avenue
London EC4Y 0DT
United Kingdom
Motif BioSciences Inc.
125 Park Avenue, 25th Floor
New York, NY 10017
United States
General: info@motifbio.com
Investors: ir@motifbio.com
© 2018 Motif Bio | Disclaimer & Terms of Use